Rasagiline and selegiline modulate mitochondrial homeostasis, intervene apoptosis system and mitigate α-synuclein cytotoxicity in disease-modifying therapy for Parkinson’s disease
Makoto Naoi, Wakako Maruyama, Masayo Shamoto‐Nagai
Topics & Concepts
RasagilineSelegilineNeuroprotectionSubstantia nigraParkinson's diseasePharmacologyMedicineOxidative stressNeurodegenerationDiseaseBioinformaticsNeuroscienceBiologyInternal medicineParkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatmentsNerve injury and regeneration